211 related articles for article (PubMed ID: 25818247)
1. The potential use of histone deacetylase inhibitors in the treatment of depression.
Fuchikami M; Yamamoto S; Morinobu S; Okada S; Yamawaki Y; Yamawaki S
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():320-4. PubMed ID: 25818247
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylases (HDACs) as therapeutic target for depressive disorders.
Misztak P; Pańczyszyn-Trzewik P; Sowa-Kućma M
Pharmacol Rep; 2018 Apr; 70(2):398-408. PubMed ID: 29456074
[TBL] [Abstract][Full Text] [Related]
3. The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression.
Meylan EM; Halfon O; Magistretti PJ; Cardinaux JR
Neuropharmacology; 2016 Aug; 107():111-121. PubMed ID: 26970016
[TBL] [Abstract][Full Text] [Related]
4. Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity.
Erburu M; Muñoz-Cobo I; Domínguez-Andrés J; Beltran E; Suzuki T; Mai A; Valente S; Puerta E; Tordera RM
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2036-48. PubMed ID: 26433268
[TBL] [Abstract][Full Text] [Related]
5. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action.
Tsankova NM; Berton O; Renthal W; Kumar A; Neve RL; Nestler EJ
Nat Neurosci; 2006 Apr; 9(4):519-25. PubMed ID: 16501568
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene.
Wei Y; Melas PA; Wegener G; Mathé AA; Lavebratt C
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25618518
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus.
Yamawaki Y; Fuchikami M; Morinobu S; Segawa M; Matsumoto T; Yamawaki S
World J Biol Psychiatry; 2012 Sep; 13(6):458-67. PubMed ID: 21812623
[TBL] [Abstract][Full Text] [Related]
8. Possible additional antidepressant-like mechanism of sodium butyrate: targeting the hippocampus.
Han A; Sung YB; Chung SY; Kwon MS
Neuropharmacology; 2014 Jun; 81():292-302. PubMed ID: 24607816
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant effect and mechanism of TMP269 on stress-induced depressive-like behavior in mice.
Meng Y; Xiao L; Liu R; Du J; Liu N; Yu J; Li Y; Lu G
Biochem Pharmacol; 2024 Jul; 225():116320. PubMed ID: 38801927
[TBL] [Abstract][Full Text] [Related]
10. [Histone acetylation, gene regulation and depression].
Vialou V
Med Sci (Paris); 2010 May; 26(5):465-7. PubMed ID: 20510142
[No Abstract] [Full Text] [Related]
11. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
12. An HDAC-dependent epigenetic mechanism that enhances the efficacy of the antidepressant drug fluoxetine.
Schmauss C
Sci Rep; 2015 Feb; 5():8171. PubMed ID: 25639887
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition.
Covington HE; Vialou VF; LaPlant Q; Ohnishi YN; Nestler EJ
Neurosci Lett; 2011 Apr; 493(3):122-6. PubMed ID: 21335060
[TBL] [Abstract][Full Text] [Related]
14. [Epigenetic mechanism of depression].
Morinobu S; Fuchikami M; Yamawaki Y; Yamamoto S; Kurata A; Yamawaki S
Seishin Shinkeigaku Zasshi; 2010; 112(10):986-91. PubMed ID: 21179661
[TBL] [Abstract][Full Text] [Related]
15. PET imaging demonstrates histone deacetylase target engagement and clarifies brain penetrance of known and novel small molecule inhibitors in rat.
Schroeder FA; Wang C; Van de Bittner GC; Neelamegam R; Takakura WR; Karunakaran A; Wey HY; Reis SA; Gale J; Zhang YL; Holson EB; Haggarty SJ; Hooker JM
ACS Chem Neurosci; 2014 Oct; 5(10):1055-62. PubMed ID: 25188794
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms associated with the antidepressant effects of the class I histone deacetylase inhibitor MS-275 in the rat ventrolateral orbital cortex.
Lin H; Geng X; Dang W; Wu B; Dai Z; Li Y; Yang Y; Zhang H; Shi J
Brain Res; 2012 Apr; 1447():119-25. PubMed ID: 22341874
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
18. Brainstem brain-derived neurotrophic factor signaling is required for histone deacetylase inhibitor-induced pain relief.
Tao W; Chen Q; Wang L; Zhou W; Wang Y; Zhang Z
Mol Pharmacol; 2015 Jun; 87(6):1035-41. PubMed ID: 25852071
[TBL] [Abstract][Full Text] [Related]
19. [Epigenetic mechanism of major depression].
Morinobu S
Seishin Shinkeigaku Zasshi; 2013; 115(11):1101-12. PubMed ID: 24450142
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors and their potential role in inflammatory bowel diseases.
Edwards AJ; Pender SL
Biochem Soc Trans; 2011 Aug; 39(4):1092-5. PubMed ID: 21787354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
